Breastfeeding News and Research

Latest Breastfeeding News and Research

Researchers find no link between infants waking up at night and later developmental problems

New parents often expect their baby to start sleeping through the night by around six months of age. Indeed, they often receive messages from pediatricians and others about the importance of early sleep consolidation.

13 Nov 2018

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.

9 Nov 2018

Breastmilk and saliva mixtures regulate oral microbiome of newborn babies

A study led by Dr Emma Sweeney and Adjunct Associate Professor Christine Knox, from QUT's Institute of Health and Biomedical Innovation, with colleagues at the University of Queensland, showed that the growth of some microbes was inhibited for up to 24 hours following breastmilk and saliva mixing.

8 Nov 2018

Researchers find no link between childhood vaccination and risk of allergy

Researchers at Karolinska Institutet in Sweden, having compared the development of allergies in children with and without the recommended vaccinations, find no support for the claim that childhood vaccination can increase the risk of allergy.

7 Nov 2018

Migration affects gut microbiota which in turn affects health find researchers

Human gut contains trillions of helpful and friendly bacteria that makes up the microbiome. These microbes are found to be greatly influential of human conditions including general health to mental health.

4 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Study: Infants born at home have more diverse bacteria in their guts, feces

Infants born at home have more diverse bacteria in their guts and feces, which may affect their developing immunity and metabolism, according to a study in Scientific Reports.

31 Oct 2018

Gene that makes some people susceptible to middle ear infections identified

Researchers at the University of Colorado Anschutz Medical Campus have found multiple genetic variants within the FUT2 gene that makes some people especially susceptible to middle ear infections.

25 Oct 2018

Survey: Only few women are informed by doctors that breastfeeding can lower cancer risk

A new survey shows that although nearly 60 percent of breastfeeding mothers knew about the link between breastfeeding and breast cancer risk reduction, just 16 percent say they learned this from a medical professional.

25 Oct 2018

Breastfeeding can have protective affect against high blood pressure in women, confirms study

A new systematic review of the literature not only confirmed that breastfeeding for as short as 1-4 months can have a protective affect against high blood pressure in women, but that lactation also can protect women across an extended follow-up of years to decades.

23 Oct 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo (nivolumab) and Yervoy (ipilimumab), versus Yervoy alone, in patients with advanced melanoma.

22 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut

A new study from the University of Helsinki shows that babies that are breastfed for at least six months have less antibiotic-resistant bacteria in their gut compared with infants breastfed for a shorter time. In addition, antibiotic use by mothers increases the number of antibiotic-resistant bacteria in infants.

15 Oct 2018

Study identifies molecular switch that controls fate of milk-producing breast cells

A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

15 Oct 2018

Kent State professor receives grant to study role of oxytocin in the developing brain

Heather Caldwell, Ph.D., a professor in Kent State University's Department of Biological Sciences, recently received a $450,000 grant to study the role that oxytocin plays in the developing brain.

12 Oct 2018

Carnegie professor receives NIH Director's New Innovator Award

Kathryn Whitehead, assistant professor of chemical engineering at Carnegie Mellon University, has been awarded a 2018 National Institutes of Health (NIH) Director's New Innovator Award for her project titled "Fate, Function, and Genetic Engineering of Breast Milk Cells for Infant Therapy."

3 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

Breastfeeding changes gene activity that regulates infant's response to stress

It has long been known that there are many physical and mental health benefits of breastfeeding for mothers and babies. But can these benefits be due to genetic changes induced by breastfeeding? New research suggests that connection.

27 Sep 2018

Breastfeeding News and Research

Latest Breastfeeding News and Research

Researchers find no link between infants waking up at night and later developmental problems

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

Breastmilk and saliva mixtures regulate oral microbiome of newborn babies

Researchers find no link between childhood vaccination and risk of allergy

Migration affects gut microbiota which in turn affects health find researchers

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Study: Infants born at home have more diverse bacteria in their guts, feces

Gene that makes some people susceptible to middle ear infections identified

Survey: Only few women are informed by doctors that breastfeeding can lower cancer risk

Breastfeeding can have protective affect against high blood pressure in women, confirms study

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut

Study identifies molecular switch that controls fate of milk-producing breast cells

Kent State professor receives grant to study role of oxytocin in the developing brain

Carnegie professor receives NIH Director's New Innovator Award

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Breastfeeding changes gene activity that regulates infant's response to stress

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breastfeeding News and Research

Latest Breastfeeding News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in